Rheumatology
News
Twelve medical groups pen letter opposing UHC copay accumulator program
“We see policies like this as sacrificing patients to the battle over high drug prices,” said Dr. Christopher Phillips.
News
Shingrix effective in older adults with preexisting immune-mediated disorders
The most common immune-mediated disorders in two phase 3 clinical trials of the vaccine were psoriasis, spondyloarthropathy, rheumatoid arthritis...
Conference Coverage
Reassuring rheumatic disease patients on value of bisphosphonates
Dr. Marcy B. Bolster addresses common patient concerns about bisphosphonate use.
News
COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate
No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments...
Conference Coverage
Mega vitamin D harms bone in women, not men, without osteoporosis
News
The evidence is not clear: Rheumatic diseases, drugs, and COVID-19
Robust is not the word to use when describing the current state of COVID-19 research.
News
Fracture risk prediction: No benefit to repeat BMD testing in postmenopausal women
But experts advise against a broad recommendation to skip repeat testing in the general population.
News
Doctors hesitated to embrace biosimilar infliximab in first 2 years
Adoption of biosimilar infliximab was initially slow, but more widely used in new patients.
News
FDA approves Tremfya (guselkumab) for psoriatic arthritis
The FDA’s approval marks the second indication for guselkumab, which was first approved for adults with plaque psoriasis in 2017.
News
ACR issues guidances for MIS-C and pediatric rheumatic disease during pandemic
The ACR appears to be the first medical organization to review all the most current evidence to issue interim guidance with the expectations that...